Rapid Molecular Testing for TB to Guide Respiratory Isolation in the U.S.: A Cost-Benefit Analysis

BACKGROUND: Respiratory isolation of inpatients during evaluation for TB is a slow and costly process in low-burden settings. Xpert MTB/RIF (Xpert) is a novel molecular test for tuberculosis (TB) that is faster and more sensitive but substantially more expensive than smear microscopy. No previous st...

Descripción completa

Detalles Bibliográficos
Autores principales: Millman, Alexander J., Dowdy, David W., Miller, Cecily R., Brownell, Robert, Metcalfe, John Z., Cattamanchi, Adithya, Davis, J. Lucian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835836/
https://www.ncbi.nlm.nih.gov/pubmed/24278155
http://dx.doi.org/10.1371/journal.pone.0079669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835836/
https://www.ncbi.nlm.nih.gov/pubmed/24278155
http://dx.doi.org/10.1371/journal.pone.0079669

Ejemplares similares